A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo.

Saved in:
Bibliographic Details
Title: A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo.
Authors: Verma MK; The Jackson Laboratory, Bar Harbor, ME, United States., Clemens J; The Jackson Laboratory, Bar Harbor, ME, United States., Burzenski L; The Jackson Laboratory, Bar Harbor, ME, United States., Sampson SB; The Jackson Laboratory, Bar Harbor, ME, United States., Brehm MA; Diabetes Center of Excellence™, Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States., Greiner DL; Diabetes Center of Excellence™, Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, United States., Shultz LD; The Jackson Laboratory, Bar Harbor, ME, United States. Electronic address: lenny.shultz@jax.org.
Source: Journal of immunological methods [J Immunol Methods] 2017 Jul; Vol. 446, pp. 47-53. Date of Electronic Publication: 2017 Apr 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7905 (Electronic) Linking ISSN: 00221759 NLM ISO Abbreviation: J Immunol Methods Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-7905
DOI:10.1016/j.jim.2017.03.021